Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 4
1982 7
1983 6
1984 4
1985 4
1986 3
1987 4
1988 3
1989 3
1990 5
1991 4
1992 17
1993 11
1994 9
1995 7
1996 4
1997 4
1998 10
1999 7
2000 4
2001 2
2002 2
2003 3
2004 1
2005 4
2006 2
2007 5
2008 18
2009 15
2010 7
2011 8
2012 1
2013 4
2015 1
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Results by year

Filters applied: . Clear all
Page 1
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.
Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; ECASS Investigators. Hacke W, et al. N Engl J Med. 2008 Sep 25;359(13):1317-29. doi: 10.1056/NEJMoa0804656. N Engl J Med. 2008. PMID: 18815396 Free article. Clinical Trial.
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group. Giovannoni G, et al. N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089960 Free article. Clinical Trial.
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.
Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group; Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G. Lees KR, et al. Lancet. 2010 May 15;375(9727):1695-703. doi: 10.1016/S0140-6736(10)60491-6. Lancet. 2010. PMID: 20472172
Hypertensive emergencies.
Krieglsteiner S, Nussbaumer K, Haring HP, Aichner F. Krieglsteiner S, et al. Among authors: aichner f. Lancet. 2000 Oct 21;356(9239):1443. doi: 10.1016/S0140-6736(05)74085-X. Lancet. 2000. PMID: 11052614 No abstract available.
Rehabilitation approaches to stroke.
Aichner F, Adelwöhrer C, Haring HP. Aichner F, et al. J Neural Transm Suppl. 2002;(63):59-73. doi: 10.1007/978-3-7091-6137-1_4. J Neural Transm Suppl. 2002. PMID: 12597609 Review.
[Diagnosis of stroke--an update].
Aichner FT. Aichner FT. Wien Med Wochenschr. 2003;153(1-2):14-20. doi: 10.1046/j.1563-258x.2003.02108.x. Wien Med Wochenschr. 2003. PMID: 12621685 Review. German.
Sneddon's syndrome. A long-term follow-up of 21 patients.
Zelger B, Sepp N, Stockhammer G, Dosch E, Hilty E, Ofner D, Aichner F, Fritsch PO. Zelger B, et al. Among authors: aichner f. Arch Dermatol. 1993 Apr;129(4):437-47. doi: 10.1001/archderm.129.4.437. Arch Dermatol. 1993. PMID: 8466214 Review.
MR-imaging of non-Alzheimer's dementia.
Aichner F, Wagner M, Kremser C, Felber S. Aichner F, et al. J Neural Transm Suppl. 1996;47:143-53. doi: 10.1007/978-3-7091-6892-9_9. J Neural Transm Suppl. 1996. PMID: 8841962 Review.
191 results